Correlation Between NYSE Composite and Homology Medicines
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Homology Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Homology Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Homology Medicines, you can compare the effects of market volatilities on NYSE Composite and Homology Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Homology Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Homology Medicines.
Diversification Opportunities for NYSE Composite and Homology Medicines
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between NYSE and Homology is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Homology Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Homology Medicines and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Homology Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Homology Medicines has no effect on the direction of NYSE Composite i.e., NYSE Composite and Homology Medicines go up and down completely randomly.
Pair Corralation between NYSE Composite and Homology Medicines
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.15 times more return on investment than Homology Medicines. However, NYSE Composite is 6.75 times less risky than Homology Medicines. It trades about 0.11 of its potential returns per unit of risk. Homology Medicines is currently generating about 0.02 per unit of risk. If you would invest 1,550,264 in NYSE Composite on August 31, 2024 and sell it today you would earn a total of 476,940 from holding NYSE Composite or generate 30.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 8.56% |
| Values | Daily Returns |
NYSE Composite vs. Homology Medicines
Performance |
| Timeline |
NYSE Composite and Homology Medicines Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Homology Medicines
Pair trading matchups for Homology Medicines
Pair Trading with NYSE Composite and Homology Medicines
The main advantage of trading using opposite NYSE Composite and Homology Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Homology Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Homology Medicines will offset losses from the drop in Homology Medicines' long position.| NYSE Composite vs. Nextplat Corp | NYSE Composite vs. Qualys Inc | NYSE Composite vs. Cadence Design Systems | NYSE Composite vs. Asure Software |
| Homology Medicines vs. Passage Bio | Homology Medicines vs. Stoke Therapeutics | Homology Medicines vs. Adaptimmune Therapeutics Plc | Homology Medicines vs. Black Diamond Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |